. Author manuscript; available in PMC: 2019 Jan 1.

Published in final edited form as: Ocul Surf. 2017 Oct 13;16(1):132–138. doi: 10.1016/j.jtos.2017.10.003

Table 1.

Demographics

Patient no.	Age/Gender	Eye	Causes	Prior treatments
1	51/F	OS	DED	ML, WC/LM, FSO, loteprednol
2	72/F	OD	DED, conjunctivochalasis	ML, WC/LM, PP, loteprednol, AST, nortriptyline
3	68/F	OS	DED, MGD/blepharitis	ML, WC/LM, loteprednol, AST
4	59/F	OS	DED, TED	ML, WC/LM, FSO, doxycycline, loteprednol, AST, TD
5	66/F	OD	DED, s/p strabismus surgery	ML, WC/LM, PP, loteprednol, TD
6	63/F	OD	MGD	ML, WC/LM, FSO, MG, MGP, loteprednol, AST, nortriptyline
		OS	MGD	ML, WC/LM, FSO, MG, MGP, loteprednol, AST, nortriptyline
7	64/F	OD	MGD	ML, WC/LM, FSO, azithromycin, doxycycline, MGP, loteprednol
8	24/M	OD	s/p PRK	ML, WC/LM, doxycycline, loteprednol, nortriptyline
9	55/F	OS	DED, conjunctivochalasis, blepharospasm	ML, WC/LM, PP, loteprednol, AST, trihexyphenidyl, BTx

AST= autologous serum tears; BTx= botulinum toxin injection; DED= dry eye disease; F= female; FSO= flaxseed oil; M= male; MG= moisture goggles; MGD= meibomian gland dysfunction; MGP= meibomian gland probing; ML= maximal lubrication; OD= right eye; OS= left eye; PP= punctal plug/s; PRK= photorefractive keratectomy; TD= testosterone drops; TED= thyroid eye disease; WC/LM= warm compresses/lid massage